- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplastic/Myeloproliferative Neoplasms in Germany
Total 6278 results
-
University of UlmTerminatedAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Germany
-
European Working Group of MDS in ChildhoodUnknownMyelodysplastic Syndromes | LeukemiaGermany, Austria, Switzerland, Czech Republic, Netherlands, Denmark, Belgium, Italy, Poland
-
BerGenBio ASAActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States, Germany, Italy, Norway
-
Technische Universität DresdenNordic Society for Pediatric Hematology and Oncology; Uniuversity of Genua,... and other collaboratorsUnknownMyeloid Leukemia, ChronicGermany
-
AstraZenecaCompletedAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | High Risk Myelodysplastic Syndrome | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma | Richter's Syndrome | T-cell Non-Hodgkin Lymphoma | Relapsed or Refractory...United Kingdom, Germany, Netherlands
-
European Organisation for Research and Treatment...UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmFrance, Belgium, Netherlands, Germany, Italy
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaGermany
-
European Organisation for Research and Treatment...CompletedMyelodysplastic SyndromesFrance, Belgium, Netherlands, Czech Republic, Italy, Germany
-
CelgeneCompletedPrimary Myelofibrosis | MPN-associated MyelofibrosisUnited States, Netherlands, France, Australia, Italy, United Kingdom, Canada, Germany, China, Spain, Belgium, Austria, Poland, Sweden, Japan, Russian Federation
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompleted
-
University of BonnPfizer; RWTH Aachen University; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaboratorsUnknownChronic Myelogenous LeukaemiaGermany
-
Fondazione per la Ricerca Ospedale MaggioreCompletedPolycythemia Vera | Essential Thrombocythemia | MyelofibrosisIsrael, United Kingdom, Czechia, Germany, Italy, Spain
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Germany, Belgium, United Kingdom
-
medac GmbHCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeGermany, Italy, Poland, France, Finland, Hungary
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromesUnited States, France, Germany
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisGermany
-
SanofiCompletedHematopoietic NeoplasmUnited States, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
Thomas Ernst, PD Dr. med.AbbVie; Ludwig-Maximilians - University of MunichRecruitingChronic Myeloid LeukemiaGermany
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, ChronicGermany
-
Fundación General de la Universidad de SalamancaCelgene CorporationCompletedMyelodysplastic SyndromeGermany, Spain, France
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Belgium, Germany, Croatia, United Kingdom, Portugal
-
CelgeneCompletedMyelodysplastic SyndromesItaly, United Kingdom, Germany, Australia, Bulgaria, France, Greece, Hungary, Netherlands, Poland, Spain
-
Imago BioSciences, Inc., a subsidiary of Merck...Active, not recruitingPrimary Myelofibrosis | Thrombocythemia, EssentialUnited States, Australia, Hong Kong, Germany, Italy, New Zealand, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited Kingdom, Germany
-
Silence Therapeutics plcCompletedNon-transfusion-dependent Thalassemia | Low Risk Myelodysplastic Syndrome | Very-Low Risk Myelodysplastic SyndromeThailand, Israel, Jordan, United Kingdom, Germany, Italy, Malaysia
-
Janssen Research & Development, LLCActive, not recruitingNeoplasms | Myelodysplastic Syndromes | Non-Hodgkin Lymphoma | Solid Tumor, AdultUnited States, Spain, Israel, Germany, Canada
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
MedImmune LLCCompletedMyelodysplastic SyndromeUnited States, United Kingdom, France, Germany
-
European Organisation for Research and Treatment...WithdrawnMyelodysplastic SyndromesFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Astex Pharmaceuticals, Inc.Active, not recruitingMyelodysplastic SyndromesSpain, United States, Belgium, Canada, Germany, Italy
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States, Canada, Netherlands, Germany, Belgium, United Kingdom
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Janssen-Cilag International NVCompletedMyelodysplastic SyndromesFrance, Germany, Bulgaria, Greece, Russian Federation
-
Gesellschaft fur Medizinische Innovation - Hamatologie...AmgenCompletedMyelodysplastic SyndromesFrance, Germany
-
CTI BioPharmaSGS S.A.CompletedMyelofibrosisMoldova, Republic of, Germany
-
Institut für Klinische Krebsforschung IKF GmbH...Celgene International II S.á.r.l.; Prof. F. Heidel, MH HannoverRecruiting
-
European Organisation for Research and Treatment...CompletedMyelodysplastic Syndromes | Leukemia | Fungal InfectionBelgium, Netherlands, Germany, France, Czechia, Slovakia
-
AbbVieTerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Australia, Germany, Israel, Italy, Japan, Spain
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Novartis PharmaceuticalsTerminatedPrimary MyelofibrosisSpain, Germany, Italy
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, Hungary
-
Keros Therapeutics, Inc.RecruitingMyelodysplastic Syndromes | CytopeniaAustralia, Spain, United States, Israel, France, Germany, New Zealand, Czechia
-
Institut de Recherches Internationales ServierCelgene CorporationActive, not recruitingUntreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS) | AML Arising From Antecedent Hematologic Disorder (AHD) | AML Arising After Exposure to Genotoxic InjuryUnited States, Germany, Netherlands
-
Janssen Research & Development, LLCCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Spain, Germany
-
CelgeneCompletedAnemiaUnited States, Belgium, Spain, United Kingdom, Austria, Canada, Germany, Portugal, France, Australia, Israel, Japan, Italy, Czechia, Poland, Turkey
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Argentina, Chile, Colombia and more
-
Kartos Therapeutics, Inc.UnknownPolycythemia VeraUnited States, Poland, Spain, Germany, Hungary, France